These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Abrupt versus gradual withdrawal of vitamin K antagonist treatment in patients with venous thromboembolic disease: assessment of hypercoagulability and clinical outcome. de Groot MR; Njo TL; van Marwijk Kooy M; Büller HR Clin Lab; 2000; 46(11-12):575-81. PubMed ID: 11109505 [TBL] [Abstract][Full Text] [Related]
28. The blue toe syndrome during oral anticoagulant therapy with acenocoumarol. Fernández MA; Andreu R; Fortea JM; Aznar J Thromb Haemost; 2001 Apr; 85(4):743. PubMed ID: 11341514 [No Abstract] [Full Text] [Related]
29. [Disseminated intravascular coagulation after oral ingestion of hydrochloric acid]. Hüttel MS Ugeskr Laeger; 1980 Apr; 142(15):962-3. PubMed ID: 7385393 [No Abstract] [Full Text] [Related]
30. Acenocoumarol and phenytoin toxicity in the presence of CYP2C9 mutation. Jose L; Binila C; Chandy SJ; Mathews JE; Mathews KP J Assoc Physicians India; 2008 Apr; 56():250-2. PubMed ID: 18702389 [TBL] [Abstract][Full Text] [Related]
31. [Safety of aspirin, clopidogrel, and acenocumarol combination in patients requiring anticoagulation]. Sánchez-Torrijos J; Gudín-Uriel M; Ridocci-Soriano F Rev Esp Cardiol; 2006 Dec; 59(12):1345-6. PubMed ID: 17194433 [No Abstract] [Full Text] [Related]
32. Clofibrate-induced myocardial injury and disseminated intravascular coagulation in a patient with chronic renal failure. Scionti L; Calafiore R; Coaccioli S; Bellomo G; Berrettini M; Puxeddu A Panminerva Med; 1984; 26(1):45-7. PubMed ID: 6728507 [No Abstract] [Full Text] [Related]
33. Delayed Allergic Reaction to Acenocoumarol With a Positive Lymphocyte Transformation Test. Dominguez-Ortega J; Entrala A; Pola-Bibian B; Gonzalez-Muñoz M; Fiandor A; Quirce S J Investig Allergol Clin Immunol; 2016; 26(4):273-4. PubMed ID: 27470649 [No Abstract] [Full Text] [Related]
35. Activated recombinant factor VII to reverse oral anticoagulants for emergent cesarean delivery. Morante L; Guasch EV; Palacio F; Gilsanz F Anesth Analg; 2006 Jun; 102(6):1902-3. PubMed ID: 16717350 [No Abstract] [Full Text] [Related]
36. [Secondary drug toxiderma to acenocoumarol]. Khammassi N; Kessentini N Pan Afr Med J; 2015; 22():95. PubMed ID: 26848342 [No Abstract] [Full Text] [Related]
37. [Syncumar necrosis and phlagmasia coerulea dolens as a complication of bronchial cancer]. Petö I; Bajtai A; Sas G; Juhász J Orv Hetil; 1982 Sep; 123(37):2299-301. PubMed ID: 7145396 [No Abstract] [Full Text] [Related]
38. [Thrombopenia and intravascular coagulation during heparin treatment]. Roussi J; Bor Y; Dechy H; Houbouyan L; Dorra M Nouv Presse Med; 1982 Jan; 11(2):132-3. PubMed ID: 7058132 [No Abstract] [Full Text] [Related]
39. [Laser in the management of syncumar necrosis]. Mester E Orv Hetil; 1981 Aug; 122(32):1995. PubMed ID: 7301366 [No Abstract] [Full Text] [Related]